Document Detail


Continuous administration of remifentanil and sufentanil induces cardioprotection in human myocardium, in vitro.
MedLine Citation:
PMID:  21615344     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Remifentanil and sufentanil are widely used opioids during general anaesthesia for cardiac and non-cardiac surgery. This study was conducted to evaluate the hypothesis that the continuous administration of remifentanil and sufentanil, at clinically relevant concentrations, could provide protection of human myocardium, in vitro, against hypoxia-reoxygenation injury. Method: Isometrically contracting isolated human right atrial trabeculae were exposed to 30 min of hypoxia and 60 min of reoxygenation. In separate groups, remifentanil at 10(-11) , 10(-10) , 10(-9) , or sufentanil at 10(-11) , 10(-10) , 10(-9)  M were administered 10 min before hypoxia until the end of the experiment. The force of contraction (FoC) of trabeculae was recorded continuously. Developed force was compared (mean ± standard deviation) between the groups using a variance analysis and post hoc tests. Results: At the end of the 60-min reoxygenation, remifentanil 10(-11)  M (FoC: 82 ± 7% of baseline), 10(-10)  M (FoC: 78 ± 5% of baseline), 10(-9)  M (FoC: 80 ± 4% of baseline) and sufentanil 10(-11)  M (FoC: 78 ± 8% of baseline), 10(-10)  M (FoC: 83 ± 6% of baseline), 10(-9)  M (FoC: 83 ± 8% of baseline) enhanced the recovery of FoC as compared with the control group (53 ± 9% of baseline, P<0.0001). Conclusions: Remifentanil and sufentanil, at clinically relevant concentrations, confer cardioprotection of human myocardium against hypoxia reoxygenation, in vitro.
Authors:
S Lemoine; L Zhu; M Massetti; J-L Gérard; J-L Hanouz
Related Documents :
10815594 - The short-term effect of apically repositioned flap surgery on the composition of the s...
6949914 - Clinical and radiographic long-term study of teeth with periodontal destruction treated...
20165744 - Treatment of infrabony defects with or without enamel matrix proteins: a 24-month follo...
11996164 - A case-control study on the psychophysical and psychological characteristics of the pha...
22885464 - Robotic-assisted or minithoracotomy incision for left ventricular lead placement: a sin...
23543204 - A 17-year experience with mitral valve repair with artificial chordae in infants and ch...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-25
Journal Detail:
Title:  Acta anaesthesiologica Scandinavica     Volume:  -     ISSN:  1399-6576     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370270     Medline TA:  Acta Anaesthesiol Scand     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 The Authors. Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.
Affiliation:
Laboratory of Experimental Anaesthesiology and Cellular Physiology EA3212, Institut Fédératif de Recherche ICORE146 Université de Caen Basse Normandie, Caen, France, Departments of Cardiac Surgery Anaesthesiology, CHU de Caen, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of metoprolol on hypoxia- and isoflurane-induced cardiac late-phase preconditioning.
Next Document:  Low central venous oxygen saturation in haemodynamically stabilized trauma patients is associated wi...